Published in Medical Letter on the CDC and FDA, March 29th, 2009
"Our R&D investment in technology has allowed us to build a robust pipeline of game-changing products focused on yield and stress," Preete will say. "We continue to be the leading company delivering innovations to farmers that help them...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.